Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis ; volume:24 ; number:1 ; day:1 ; month:9 ; year:2022 ; pages:1-17 ; date:12.2022
Arthritis Research & Therapy ; 24, Heft 1 (1.9.2022), 1-17, 12.2022
- Creator
-
Kondo, Masahiro
Suzuki, Tsuyoshi
Kawano, Yuko
Kojima, Shinji
Miyashiro, Masahiko
Matsumoto, Atsuhiro
Kania, Gabriela
Błyszczuk, Przemysław
Ross, Rebecca L.
Mulipa, Panji
Galdo, Francesco Del
Zhang, Yun
Distler, Jörg H. W.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-022-02899-3
- URN
-
urn:nbn:de:101:1-2022111909082881301156
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kondo, Masahiro
- Suzuki, Tsuyoshi
- Kawano, Yuko
- Kojima, Shinji
- Miyashiro, Masahiko
- Matsumoto, Atsuhiro
- Kania, Gabriela
- Błyszczuk, Przemysław
- Ross, Rebecca L.
- Mulipa, Panji
- Galdo, Francesco Del
- Zhang, Yun
- Distler, Jörg H. W.
- SpringerLink (Online service)
Other Objects (12)
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability
Predicting doped Fe-based superconductor critical temperature from structural and topological parameters using machine learning
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
Application of AgNPs in biomedicine: An overview and current trends
Pattern Recognition to Identify Stroke in the Cognitive Profile: Secondary Analyses of a Prospective Cohort Study
Therapeutic molecular targets of SSc-ILD
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
DC-YOLO: an improved field plant detection algorithm based on YOLOv7-tiny
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions
Pharmacological inhibition of porcupine as monotherapy or in combination with ruxolitinib, ibrutinib or belumosudil in experimental sclerodermatous chronic graft-versus-host disease
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability
Predicting doped Fe-based superconductor critical temperature from structural and topological parameters using machine learning
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
Application of AgNPs in biomedicine: An overview and current trends
Pattern Recognition to Identify Stroke in the Cognitive Profile: Secondary Analyses of a Prospective Cohort Study
Therapeutic molecular targets of SSc-ILD
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
DC-YOLO: an improved field plant detection algorithm based on YOLOv7-tiny
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions
Pharmacological inhibition of porcupine as monotherapy or in combination with ruxolitinib, ibrutinib or belumosudil in experimental sclerodermatous chronic graft-versus-host disease
Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability
Predicting doped Fe-based superconductor critical temperature from structural and topological parameters using machine learning
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
Application of AgNPs in biomedicine: An overview and current trends
Pattern Recognition to Identify Stroke in the Cognitive Profile: Secondary Analyses of a Prospective Cohort Study
Therapeutic molecular targets of SSc-ILD
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
DC-YOLO: an improved field plant detection algorithm based on YOLOv7-tiny
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions